Literature DB >> 11488532

Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture.

N Nagai1, S Yamamoto, T Tsuboi, H Ihara, T Urano, Y Takada, S Terakawa, A Takada.   

Abstract

Effect of tissue-type plasminogen activator (tPA) on oxygen-glucose deprivation (OGD) was studied in cultured cortical neurons prepared from tPA gene knockout (tPA-KO) and wild-type (Wt) mice. Three hours of OGD induced 45% and 23% of neuronal death in Wt and tPA-KO mice, respectively. Neuronal death in tPA-KO mice was increased to 42% by additional tPA. Six hours of OGD induced 80% and 40% of neuronal death in Wt and tPA-KO mice, respectively, whereas the addition of tPA increased to 62% in tPA-KO mice. These results suggest that tPA is directly involved in the process of neuronal death induced by ischemia-mimic stress without involving vascular or circulatory components.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488532     DOI: 10.1097/00004647-200106000-00001

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  11 in total

1.  Tissue Plasminogen Activator: Side Effects and Signaling.

Authors:  Ling Lin; Kebin Hu
Journal:  J Drug Des Res       Date:  2014-09-25

Review 2.  Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.

Authors:  Sherrefa R Burchell; Jiping Tang; John H Zhang
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

3.  Essential role of interleukin-6 in post-stroke angiogenesis.

Authors:  Karen Gertz; Golo Kronenberg; Roland E Kälin; Tina Baldinger; Christian Werner; Mustafa Balkaya; Gina D Eom; Julian Hellmann-Regen; Jan Kröber; Kelly R Miller; Ute Lindauer; Ulrich Laufs; Ulrich Dirnagl; Frank L Heppner; Matthias Endres
Journal:  Brain       Date:  2012-04-03       Impact factor: 13.501

Review 4.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

5.  Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Seong H Cho; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

6.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Authors:  Kebin Hu; Chuanyue Wu; Wendy M Mars; Youhua Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 7.  Novel actions of tissue-type plasminogen activator in chronic kidney disease.

Authors:  Kebin Hu; Wendy M Mars; Youhua Liu
Journal:  Front Biosci       Date:  2008-05-01

8.  Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia.

Authors:  Faisal Adhami; Dan Yu; Wei Yin; Aryn Schloemer; Kevin A Burns; Guanghong Liao; Jay L Degen; Jun Chen; Chia-Yi Kuan
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

Review 9.  Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.

Authors:  Ling Lin; Kebin Hu
Journal:  Am J Clin Exp Immunol       Date:  2014-02-27

10.  Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia.

Authors:  S-R Lee; J Lok; A Rosell; H-Y Kim; Y Murata; D Atochin; P L Huang; X Wang; C Ayata; M A Moskowitz; E H Lo
Journal:  Neuroscience       Date:  2007-10-23       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.